Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Brain Neoplasms 3Small Cell Lung Carcinoma 1Neoplasm Metastasis 1Lung Neoplasms 1Glioblastoma 1Fatigue 1Cognition Disorders 1Central Nervous System Carcinoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Mental Status and Dementia Tests × Clear all
NCT00343616 2012-07-27

Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

ETOP IBCSG Partners Foundation

Phase 3 Completed
135 enrolled
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡